Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib

AIM: To investigate in greater detail the efficacy and safety of sorafenib for the treatment of hepatocellular carcinoma (HCC) in patients with established cirrhosis. METHODS: From October 2009 to July 2012 patients with an established diagnosis of cirrhosis and HCC treated with sorafenib were conse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Inghilesi, Andrea L, Gallori, Donatella, Antonuzzo, Lorenzo, Forte, Paolo, Tomcikova, Daniela, Arena, Umberto, Colagrande, Stefano, Pradella, Silvia, Fani, Bernardo, Gianni, Elena, Boni, Luca, Laffi, Giacomo, Costanzo, Francesco Di, Marra, Fabio
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Co., Limited 2014
Matèries:
Brief Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3921487/
https://ncbi.nlm.nih.gov/pubmed/24574751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i3.786
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars